Clinical Trial: A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109

Study Status: Suspended
Recruit Status: Suspended
Study Type: Interventional




Official Title: A Phase 2 Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109 Administered in Multi Intramuscular Doses to Healthy Subjects

Brief Summary: The purpose of this study is to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109 Administered in Multi Intramuscular Doses to Healthy Subjects.